ONCOFUSION THERAPEUTICS
OncoFusion Therapeutics Inc. discovers and develops personalized therapeutics for patients with genetically defined cancers. It focuses on bromodomain inhibitors, ERG inhibitors, EZH-2-EED inhibitors, and MMSET/NSD 2 inhibitors. The company was founded in 2012 and is based in Ann Arbor, Michigan.
ONCOFUSION THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.oncofusion.com
Total Employee:
1+
Status:
Active
Contact:
48109-2590
Email Addresses:
[email protected]
Total Funding:
525 K USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Sectigo SSL Sectigo Domain SSL Unified Layer BlueHost Microsoft DNS
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.oncofusion.com
- Host name: box509.bluehost.com
- IP address: 74.220.219.109
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
